| Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation. | |
| | |
MedLine Citation:
|
PMID: 20680157 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Pharmacogenetics is the study of genetic basis in the individual response to drugs. A thorough knowledge of this will lead to a future where tailor-made drugs, suiting an individual, can be used. Scandinavian countries have been known for wide usage of pharmacogenetics and the most widely used application is for genotyping CYP2D6 in treating psychiatric illness. The CYP-450 enzyme, a super family of microsomal drug-metabolizing enzymes, is the most important of enzymes that catalyzes phase-I drug metabolism reaction. CYP2D6 is a member of this family and it has been most intensively studied and the best example of pharmacogenetics variation in drug metabolism. Neuro-transmitter and drug acting CNS viz. codeine, dextromethorphan, metoprolol and tryptyline etc. are well metabolized by this enzyme. Thus, CYP2D6 is one of the most important and responsible enzymes which regulates bioavailability and metabolism of drug. Presently 75 alleles of CYP2D6 have been described which are responsible for variance of metabolism and toxicity of drugs. Thus, by determining variance of CYP2D6 using molecular approaches viz., PCR, real-time PCR, DNA micro-array and molecular docking can determine the adverse effects, drug toxicity, bioavailability and therapeutic potential of new drug. |
| | |
Authors:
|
Kapil Kalra; Garima Jarmal; Neeti Mishra |
Related Documents
:
|
17957727 - Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th annive... 18784617 - Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel ... 15202517 - Ethical considerations on pharmacogenomics. 17363477 - Targeted therapeutics for multiple myeloma: the arrival of a risk-stratified approach. 6149907 - The metabolism and excretion of buprenorphine in humans. 12846597 - Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome p45... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Indian journal of human genetics Volume: 15 ISSN: 0971-6866 ISO Abbreviation: Indian J Hum Genet Publication Date: 2009 May |
Date Detail:
|
Created Date: 2010-08-03 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101223637 Medline TA: Indian J Hum Genet Country: India |
Other Details:
|
Languages: eng Pagination: 78-83 Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rare association of Turner syndrome with neurofibromatosis type 1 and tuberous sclerosis complex.
Next Document: Achalasia - an update.